{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:41:49Z","timestamp":1789094509762,"version":"build-2803163510"},"reference-count":125,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005802","name":"Ministerul Cercet\u0103rii \u0219i Inov\u0103rii","doi-asserted-by":"publisher","award":["565\/C1.2.PFE-CDI.202"],"award-info":[{"award-number":["565\/C1.2.PFE-CDI.202"]}],"id":[{"id":"10.13039\/501100005802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The increasing burden on human malignant diseases became a major concern for healthcare practitioners, that must deal with tumor relapse and the inability to efficiently treat metastasis, in addition to side effects. Throughout the decades, many therapeutic strategies have been employed to improve the clinical outcomes of cancer patients and great efforts have been made to develop more efficient and targeted medicines. The malignant cell is characterized by genetic and epigenetic modifications, therefore targeting those specific drivers of carcinogenesis is highly desirable. Among the genome editing technologies, CRISPR\/Cas9 stood as a promising candidate for cancer treatment alternatives, due to its low complexity design. First described as a defense mechanism of bacteria against invading foreign DNA, later it was shown that CRISPR components can be engineered to target specific DNA sequences in a test tube, a discovery that was awarded later with the Nobel Prize in chemistry for its rapid expansion as a reliable genome editing tool in many fields of research, including medicine. The present paper aims of describing CRISPR\/Cas9 potential targets for malignant disorders, and the approaches used for achieving this goal. Aside from preclinical studies, we also present the clinical trials that use CRISPR-based technology for therapeutic purposes of cancer. Finally, a summary of the presented studies adds a more focused view of the therapeutic value CRISPR\/Cas9 holds and the associated shortcomings.<\/jats:p>","DOI":"10.3390\/cells11182781","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T20:52:51Z","timestamp":1662497571000},"page":"2781","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Genome Editing Approaches with CRISPR\/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research"],"prefix":"10.3390","volume":"11","author":[{"given":"Sergiu","family":"Chira","sequence":"first","affiliation":[{"name":"Research Center for Functional Genomics, Biomedicine and Translational Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2436-0903","authenticated-orcid":false,"given":"Andreea","family":"Nutu","sequence":"additional","affiliation":[{"name":"Research Center for Functional Genomics, Biomedicine and Translational Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ecaterina","family":"Isacescu","sequence":"additional","affiliation":[{"name":"Research Center for Functional Genomics, Biomedicine and Translational Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Bica","sequence":"additional","affiliation":[{"name":"Research Center for Functional Genomics, Biomedicine and Translational Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5806-0220","authenticated-orcid":false,"given":"Laura","family":"Pop","sequence":"additional","affiliation":[{"name":"Research Center for Functional Genomics, Biomedicine and Translational Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0625-4445","authenticated-orcid":false,"given":"Cristina","family":"Ciocan","sequence":"additional","affiliation":[{"name":"Research Center for Functional Genomics, Biomedicine and Translational Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5828-1325","authenticated-orcid":false,"given":"Ioana","family":"Berindan-Neagoe","sequence":"additional","affiliation":[{"name":"Research Center for Functional Genomics, Biomedicine and Translational Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jcyt.2014.10.015","article-title":"Human Mesenchymal Stromal Cell Therapy for Prevention and Recovery of Chemo\/Radiotherapy Adverse Reactions","volume":"17","author":"Hendijani","year":"2015","journal-title":"Cytotherapy"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3892\/ijo.2018.4661","article-title":"From Chemotherapy to Biological Therapy: A Review of Novel Concepts to Reduce the Side Effects of Systemic Cancer Treatment (Review)","volume":"54","author":"Schirrmacher","year":"2019","journal-title":"Int. J. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41585-021-00486-w","article-title":"Secondary Malignancy after Radiotherapy: Not Always a Secondary Concern","volume":"18","author":"Reddy","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0360-3016(03)00594-7","article-title":"Cardiovascular Death and Second Non-Breast Cancer Malignancy after Postmastectomy Radiation and Doxorubicin-Based Chemotherapy","volume":"57","author":"Woodward","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_6","first-page":"1222","article-title":"Second Cancers and Late Toxicities after Treatment of Aggressive Non-Hodgkin Lymphoma with the ACVBP Regimen: A GELA Cohort Study on 2837 Patients","volume":"103","author":"Mounier","year":"2004","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3121\/cmr.4.3.218","article-title":"Gene Therapy for Cancer Treatment: Past, Present and Future","volume":"4","author":"Cross","year":"2006","journal-title":"Clin. Med. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41417-019-0121-y","article-title":"Recording 25 Years of Progress in Cancer Gene Therapy","volume":"26","author":"Libutti","year":"2019","journal-title":"Cancer Gene Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"30675","DOI":"10.18632\/oncotarget.5169","article-title":"Progresses towards Safe and Efficient Gene Therapy Vectors","volume":"6","author":"Chira","year":"2015","journal-title":"Oncotarget"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR Provides Against Viruses in Prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12943-022-01552-6","article-title":"CRISPR Based Therapeutics: A New Paradigm in Cancer Precision Medicine","volume":"21","author":"Das","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jconrel.2022.02.005","article-title":"Current Approaches in CRISPR-Cas9 Mediated Gene Editing for Biomedical and Therapeutic Applications","volume":"343","author":"Bhattacharjee","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1128\/jb.169.12.5429-5433.1987","article-title":"Nucleotide Sequence of the Iap Gene, Responsible for Alkaline Phosphatase Isoenzyme Conversion in Escherichia Coli, and Identification of the Gene Product","volume":"169","author":"Ishino","year":"1987","journal-title":"J. Bacteriol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1046\/j.1365-2958.2002.02839.x","article-title":"Identification of Genes That Are Associated with DNA Repeats in Prokaryotes","volume":"43","author":"Jansen","year":"2002","journal-title":"Mol. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2958.1995.mmi_17010085.x","article-title":"Long Stretches of Short Tandem Repeats Are Present in the Largest Replicons of the Archaea Haloferax Mediterranei and Haloferax Volcanii and Could Be Involved in Replicon Partitioning","volume":"17","author":"Mojica","year":"1995","journal-title":"Mol. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1099\/mic.0.28048-0","article-title":"Clustered Regularly Interspaced Short Palindrome Repeats (CRISPRs) Have Spacers of Extrachromosomal Origin","volume":"151","author":"Bolotin","year":"2005","journal-title":"Microbiology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1099\/mic.0.27437-0","article-title":"CRISPR Elements in Yersinia Pestis Acquire New Repeats by Preferential Uptake of Bacteriophage DNA, and Provide Additional Tools for Evolutionary Studies","volume":"151","author":"Pourcel","year":"2005","journal-title":"Microbiology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41579-019-0299-x","article-title":"Evolutionary Classification of CRISPR\u2013Cas Systems: A Burst of Class 2 and Derived Variants","volume":"18","author":"Makarova","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/d41586-020-02765-9","article-title":"Pioneers of Revolutionary CRISPR Gene Editing Win Chemistry Nobel","volume":"586","author":"Ledford","year":"2020","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex Genome Engineering Using CRISPR\/Cas Systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-Guided Human Genome Engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.bbrc.2005.07.089","article-title":"Design, Engineering, and Characterization of Zinc Finger Nucleases","volume":"335","author":"Mani","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt.1755","article-title":"A TALE Nuclease Architecture for Efficient Genome Editing","volume":"29","author":"Miller","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4161\/sgtp.1.1.12178","article-title":"Ras History: The Saga Continues","volume":"1","author":"Cox","year":"2010","journal-title":"Small GTPases"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"102309","DOI":"10.1016\/j.ctrv.2021.102309","article-title":"KRAS Inhibitors\u2014Yes but What next? Direct Targeting of KRAS\u2014Vaccines, Adoptive T Cell Therapy and Beyond","volume":"101","author":"Nagasaka","year":"2021","journal-title":"Cancer Treat. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2020.03.015","article-title":"Genome Editing of Mutant KRAS through Supramolecular Polymer-Mediated Delivery of Cas9 Ribonucleoprotein for Colorectal Cancer Therapy","volume":"322","author":"Wan","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.7150\/thno.42325","article-title":"Selective Targeting of the Oncogenic \\textit KRAS G12S Mutant Allele by CRISPR\/Cas9 Induces Efficient Tumor Regression","volume":"10","author":"Gao","year":"2020","journal-title":"Theranostics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41374-018-0056-1","article-title":"Specific Targeting of Point Mutations in EGFR L858R\u2014Positive Lung Cancer by CRISPR\/Cas9","volume":"98","author":"Cheung","year":"2018","journal-title":"Lab. Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1093\/nar\/gkx490","article-title":"Selective Disruption of an Oncogenic Mutant Allele by CRISPR\/Cas9 Induces Efficient Tumor Regression","volume":"45","author":"Koo","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1593\/tlo.09250","article-title":"Targeting P53 for Novel Anticancer Therapy","volume":"3","author":"Wang","year":"2010","journal-title":"Transl. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","article-title":"Mutant P53 in Cancer: New Functions and Therapeutic Opportunities","volume":"25","author":"Muller","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/jor.24227","article-title":"Targeting Mutant TP53 as a Potential Therapeutic Strategy for the Treatment of Osteosarcoma","volume":"37","author":"Tang","year":"2019","journal-title":"J. Orthop. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/carcin\/bgaa048","article-title":"Targeting RLIP with CRISPR\/Cas9 Controls Tumor Growth","volume":"42","author":"Singhal","year":"2021","journal-title":"Carcinogenesis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3892\/or.2013.2281","article-title":"Degradation of P53 by Natural Variants of the E6 Protein of Human Papillomavirus Type 16","volume":"29","author":"Yi","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_37","first-page":"2197","article-title":"CRISPR\/Cas9-mediated Cervical Cancer Treatment Targeting Human Papillomavirus E6","volume":"17","author":"Yoshiba","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Ehrke-Schulz, E., Heinemann, S., Schulte, L., Schiwon, M., and Ehrhardt, A. (2020). Adenoviral Vectors Armed with PAPILLOMAVIRUs Oncogene Specific CRISPR\/Cas9 Kill Human\u2014Papillomavirus\u2014Induced Cervical Cancer Cells. Cancers, 12.","DOI":"10.3390\/cancers12071934"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1038\/s41598-022-06025-w","article-title":"Antiproliferative Effects of AAV\u2014Delivered CRISPR\/Cas9\u2014Based Degradation of the HPV18\u2014E6 Gene in HeLa Cells","volume":"12","author":"Noroozi","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.ymthe.2019.08.012","article-title":"Systemic Delivery of CRISPR\/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors","volume":"27","author":"Jubair","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41417-019-0131-9","article-title":"Synergistic Antitumor Effect on Cervical Cancer by Rational Combination of PD1 Blockade and CRISPR\u2014Cas9\u2014Mediated HPV Knockout","volume":"27","author":"Zhen","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/bjc.2017.434","article-title":"Mechanisms of Resistance to Immune Checkpoint Inhibitors","volume":"118","author":"Jenkins","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1158\/0008-5472.CAN-11-1271","article-title":"A Novel MLL5 Isoform That Is Essential to Activate E6 and E7 Transcription in HPV16\/18-Associated Cervical Cancers","volume":"71","author":"Yew","year":"2011","journal-title":"Cancer Res."},{"key":"ref_44","first-page":"170","article-title":"CRISPR\/Cas9\u2014Mediated Knockout of MLL5 Enhances Apoptotic Effect of Cisplatin in HeLa Cells in Vitro","volume":"19","author":"Pirouzfar","year":"2020","journal-title":"EXCLI J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3389\/fcimb.2021.590989","article-title":"The Use of CRISPR\/Cas9 as a Tool to Study Human Infectious Viruses","volume":"11","author":"Lin","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s15010-020-01554-w","article-title":"CRISPR-Based Strategies in Infectious Disease Diagnosis and Therapy","volume":"49","author":"Binnie","year":"2021","journal-title":"Infection"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"112743","DOI":"10.1016\/j.biopha.2022.112743","article-title":"Therapeutic Potentials of CRISPR-Cas Genome Editing Technology in Human Viral Infections","volume":"148","author":"Najafi","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1002\/jmv.27046","article-title":"Reversible Switching of Primary Cells between Normal and Malignant State by Oncogenic Virus KSHV and CRISPR\/Cas9-Mediated Targeting of a Major Viral Latent Protein","volume":"93","author":"Ju","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Haslauer, T., Greil, R., Zaborsky, N., and Geisberger, R. (2021). Car T-Cell Therapy in Hematological Malignancies. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168996"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/cas.14799","article-title":"Preclinical and Clinical Advances in Dual-Target Chimeric Antigen Receptor Therapy for Hematological Malignancies","volume":"112","author":"Guo","year":"2021","journal-title":"Cancer Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13287-020-02128-1","article-title":"CAR T Cells in Solid Tumors: Challenges and Opportunities","volume":"12","author":"Marofi","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3389\/fphar.2018.01118","article-title":"Disruption of PD-1 Enhanced the Anti-Tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma","volume":"9","author":"Guo","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Nakazawa, T., Natsume, A., Nishimura, F., Morimoto, T., Matsuda, R., Nakamura, M., Yamada, S., Nakagawa, I., Motoyama, Y., and Park, Y.-S. (2020). Effect of CRISPR\/Cas9\u2014Mediated PD-1-Disrupted Primary Human Third\u2014Generation CAR\u2014T Cells Targeting EGFRvIII on In Vitro Human Glioblastoma Cell Growth. Cells, 9.","DOI":"10.3390\/cells9040998"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e133977","DOI":"10.1172\/jci.insight.133977","article-title":"TGF-\u03b2 Inhibition via CRISPR Promotes the Long-Term Efficacy of CAR T Cells against Solid Tumors","volume":"5","author":"Tang","year":"2020","journal-title":"JCI Insight"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00262-018-2281-2","article-title":"CRISPR\/Cas9-Mediated PD-1 Disruption Enhances Human Mesothelin-Targeted CAR T Cell Effector Functions","volume":"68","author":"Hu","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1158\/0008-5472.CAN-18-0030","article-title":"CRISPR\/Cas9\u2014Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells","volume":"78","author":"Jung","year":"2018","journal-title":"Cancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.gene.2017.09.010","article-title":"CRISPR Knock out CTLA-4 Enhances the Anti-Tumor Activity of Cytotoxic T Lymphocytes","volume":"636","author":"Shi","year":"2017","journal-title":"Gene"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e01039","DOI":"10.1016\/j.heliyon.2018.e01039","article-title":"Targeting B7\u2014H1 (PD\u2014L1) Sensitizes Cancer Cells to Chemotherapy","volume":"4","author":"Wu","year":"2018","journal-title":"Heliyon"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2022.01.010","article-title":"Disrupting PHF8\u2014TOPBP1 Connection Elicits a Breast Tumor-Specific Vulnerability to Chemotherapeutics","volume":"530","author":"Ma","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00280-009-1212-5","article-title":"Successful Rechallenge with Erlotinib in a Patient with EGFR-Mutant Lung Adenocarcinoma Who Developed Gefitinib-Related Interstitial Lung Disease","volume":"65","author":"Fukui","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jmoldx.2012.10.002","article-title":"Frequency and Spectrum of BRAF Mutations in a Retrospective, Single-Institution Study of 1112 Cases of Melanoma","volume":"15","author":"Greaves","year":"2013","journal-title":"J. Mol. Diagn."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"606593","DOI":"10.3389\/fmolb.2020.606593","article-title":"A Blue Light\u2014Inducible CRISPR\u2014Cas9 System for Inhibiting Progression of Melanoma Cells","volume":"7","author":"Wu","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Mauri, G., Bonazzina, E., Amatu, A., Tosi, F., Bencardino, K., Gori, V., Massihnia, D., Cipani, T., Spina, F., and Ghezzi, S. (2021). The Evolutionary Landscape of Treatment for BRAFv600e Mutant Metastatic Colorectal Cancer. Cancers, 13.","DOI":"10.3390\/cancers13010137"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/14737140.2019.1686979","article-title":"The Landscape of Tyrosine Kinase Inhibitors in Sarcomas: Looking beyond Pazopanib","volume":"19","author":"Wilding","year":"2019","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-018-0003-x","article-title":"Ewing Sarcoma","volume":"4","author":"Surdez","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Cervera, S.T., Rodr\u00edguez-Mart\u00edn, C., Fern\u00e1ndez-Tabanera, E., de Mera, R.M., Morin, M., Fern\u00e1ndez-Pe\u00f1alver, S., Iranzo-Mart\u00ednez, M., Amhih-Cardenas, J., Garc\u00eda-Garc\u00eda, L., and Gonz\u00e1lez-Gonz\u00e1lez, L. (2021). Therapeutic Potential of EWSR1\u2014FLI1 Inactivation by CRISPR\/Cas9 in Ewing Sarcoma. Cancers, 13.","DOI":"10.3390\/cancers13153783"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1038\/s41467-020-18875-x","article-title":"In Vivo CRISPR\/Cas9 Targeting of Fusion Oncogenes for Selective Elimination of Cancer Cells","volume":"11","author":"Martin","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.2147\/OTT.S197535","article-title":"Tumor Necrosis Factor \u03b1 Knockout Impaired Tumorigenesis in Chronic Myeloid Leukemia Cells Partly by Metabolism Modification and miRNA Regulation","volume":"12","author":"Shen","year":"2019","journal-title":"OncoTargets Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"577420","DOI":"10.3389\/fonc.2020.577420","article-title":"Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment","volume":"10","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","article-title":"Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer","volume":"31","author":"Snaebjornsson","year":"2020","journal-title":"Cell Metab."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3892\/or.2021.8234","article-title":"ELOVL2 Promotes Cancer Progression by Inhibiting Cell Apoptosis in Renal Cell Carcinoma","volume":"47","author":"Tanaka","year":"2021","journal-title":"Oncol. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1038\/s41388-021-01882-7","article-title":"CRISPR Screens Identify Cholesterol Biosynthesis as a Therapeutic Target on Stemness and Drug Resistance of Colon Cancer","volume":"40","author":"Gao","year":"2021","journal-title":"Oncogene"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-0716-1581-2_12","article-title":"CRISPR\/Cas9 to Silence Long Non-Coding RNAs","volume":"2348","author":"Rosenlund","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"12135","DOI":"10.1093\/nar\/gkaa1051","article-title":"Generation of Onco-Enhancer Enhances Chromosomal Remodeling and Accelerates Tumorigenesis","volume":"48","author":"Chai","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"G\u0142\u00f3w, D., Maire, C.L., Schwarze, L.I., Lamszus, K., and Fehse, B. (2021). CRISPR-to-Kill (C2K)\u2014Employing the Bacterial Immune System to Kill Cancer Cells. Cancers, 13.","DOI":"10.3390\/cancers13246306"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/gb-2011-12-12-236","article-title":"Alu Elements: Know the SINEs","volume":"12","author":"Deininger","year":"2011","journal-title":"Genome Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1038\/mtna.2015.37","article-title":"Off-Target Effects in CRISPR\/Cas9-Mediated Genome Engineering","volume":"4","author":"Zhang","year":"2015","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nbt.2808","article-title":"Improving CRISPR-Cas Nuclease Specificity Using Truncated Guide RNAs","volume":"32","author":"Fu","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gky222","article-title":"Paired D10A Cas9 Nickases Are Sometimes More Efficient than Individual Nucleases for Gene Disruption","volume":"46","author":"Gopalappa","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"De Santa-Inez, D.C., Fuziwara, C.S., Saito, K.C., and Kimura, E.T. (2021). Targeting the Highly Expressed microRNA miR-146b with CRISPR\/Cas9n Gene Editing System in Thyroid Cancer. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22157992"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"663225","DOI":"10.3389\/fonc.2021.663225","article-title":"CRISPR\/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines","volume":"11","author":"Biagioni","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"657145","DOI":"10.3389\/fmolb.2021.657145","article-title":"Knockdown of Long Non-Coding RNA SNGH3 by CRISPR\u2014dCas9 Inhibits the Progression of Bladder Cancer","volume":"8","author":"Cao","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"29220","DOI":"10.18632\/oncotarget.25678","article-title":"Development of an Integrated CRISPRi Targeting \u0394Np63 for Treatment of Squamous Cell Carcinoma","volume":"9","author":"Yoshida","year":"2018","journal-title":"Oncotarget"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, Histone Deacetylation and Gene Transcription: From Molecular Biology to Cancer Therapeutics","volume":"17","author":"Gallinari","year":"2007","journal-title":"Cell Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"105304","DOI":"10.1016\/j.phrs.2020.105304","article-title":"A CRISPR\u2014Cas9 Repressor for Epigenetic Silencing of KRAS","volume":"164","author":"Liu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1479-0556-2-9","article-title":"The Use of Retroviral Vectors for Gene Therapy-What Are the Risks? A Review of Retroviral Pathogenesis and Its Relevance to Retroviral Vector-Mediated Gene Delivery","volume":"2","author":"Anson","year":"2004","journal-title":"Genet. Vaccines Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical Use of Lentiviral Vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.mt.6300028","article-title":"PiggyBac Transposon-Mediated Gene Transfer in Human Cells","volume":"15","author":"Wilson","year":"2007","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2174\/156652311797415836","article-title":"Transposon-Mediated Gene Transfer into Adult and Induced Pluripotent Stem Cells","volume":"11","author":"Belay","year":"2011","journal-title":"Curr. Gene Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1128\/JVI.01865-08","article-title":"Insertional Gene Activation by Lentiviral and Gammaretroviral Vectors","volume":"83","author":"Bokhoven","year":"2009","journal-title":"J. Virol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e201900367","DOI":"10.26508\/lsa.201900367","article-title":"Gene Editing Enables T-Cell Engineering to Redirect Antigen Specificity for Potent Tumor Rejection","volume":"2","author":"Albers","year":"2019","journal-title":"Life Sci. Alliance"},{"key":"ref_93","first-page":"1","article-title":"Targeted Core-Shell Nanoparticles for Precise CTCF Gene Insert in Treatment of Metastatic Breast Cancer","volume":"11","author":"Duan","year":"2022","journal-title":"Bioact. Mater."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nbt.3843","article-title":"Targeting Genomic Rearrangements in Tumor Cells through Cas9-Mediated Insertion of a Suicide Gene","volume":"35","author":"Chen","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"eaba7365","DOI":"10.1126\/science.aba7365","article-title":"CRISPR-Engineered T Cells in Patients with Refractory Cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Science"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41591-020-0840-5","article-title":"Safety and Feasibility of CRISPR-Edited T Cells in Patients with Refractory Non-Small-Cell Lung Cancer","volume":"26","author":"Lu","year":"2020","journal-title":"Nat. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1053\/j.gastro.2016.12.036","article-title":"MAN2A1\u2013FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice","volume":"153","author":"Chen","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.18632\/oncotarget.26918","article-title":"Detection of Fusion Transcripts in the Serum Samples of Patients with Hepatocellular Carcinoma","volume":"10","author":"Yu","year":"2019","journal-title":"Oncotarget"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.ajpath.2014.06.025","article-title":"Novel Fusion Transcripts Associate with Progressive Prostate Cancer","volume":"184","author":"Yu","year":"2014","journal-title":"Am. J. Pathol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.omto.2020.09.004","article-title":"A New Tool for CRISPR\u2014Cas13a\u2014Based Cancer Gene Therapy","volume":"19","author":"Gao","year":"2020","journal-title":"Mol. Ther. -Oncolytics"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Lin, C.-L., Tsai, M.-L., Lin, C.-Y., Hsu, K.-W., Hsieh, W.-S., Chi, W.-M., Huang, L.-C., and Lee, C.-H. (2019). HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020454"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"120275","DOI":"10.1016\/j.biomaterials.2020.120275","article-title":"Virus-like Nanoparticle as a Co-Delivery System to Enhance Efficacy of CRISPR\/Cas9-Based Cancer Immunotherapy","volume":"258","author":"Liu","year":"2020","journal-title":"Biomaterials"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Chira, S., Nutu, A., Bica, C., Pop, L., Gherman, M., Angheluta, M., and Berindan-Neagoe, I. (Handbook of Cancer and Immunology, 2022). Turning tables for CRISPR\/Cas9 editing system: From scratch to advanced delivery platforms, Handbook of Cancer and Immunology, accepted for publication.","DOI":"10.1007\/978-3-030-80962-1_292-1"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Peng, L., Pan, P., Chen, J., Yu, X., Wu, J., and Chen, Y. (2018). A Tetracycline-inducible CRISPR\/Cas9 System, Targeting Two Long Non-coding RNAs, Suppresses the Malignant Behavior of Bladder Cancer Cells. Oncol. Lett.","DOI":"10.3892\/ol.2018.9157"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"607740","DOI":"10.3389\/fmolb.2020.607740","article-title":"CRISPR\u2014Cas13a Targeting the Enhancer RNA\u2014SMAD7e Inhibits Bladder Cancer Development Both in Vitro and in Vivo","volume":"7","author":"Che","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"646412","DOI":"10.3389\/fmolb.2021.646412","article-title":"Engineered CRISPR\/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer In Vitro","volume":"8","author":"Zhuang","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12943-022-01517-9","article-title":"Targeting HNRNPU to Overcome Cisplatin Resistance in Bladder Cancer","volume":"21","author":"Shi","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Wen, L., Zhao, C., Song, J., Ma, L., Ruan, J., Xia, X., Chen, Y.E., Zhang, J., Ma, P.X., and Xu, J. (2020). CRISPR\/Cas9\u2014Mediated TERT Disruption in Cancer Cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020653"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.omto.2021.12.011","article-title":"Gene Knock-out Chain Reaction Enables High Disruption Efficiency of HPV18 E6\/E7 Genes in Cervical Cancer Cells","volume":"24","author":"Tian","year":"2022","journal-title":"Mol. Ther.-Oncolytics"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"St\u00f6ckl, S., Lindner, G., Li, S., Schuster, P., Haferkamp, S., Wagner, F., Prodinger, P.M., Multhoff, G., Boxberg, M., and Hillmann, A. (2020). SOX9 Knockout Induces Polyploidy and Changes Sensitivity to Tumor Treatment Strategies in a Chondrosarcoma Cell Line. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207627"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ijc.31374","article-title":"Caspase-3 Regulates the Migration, Invasion and Metastasis of Colon Cancer Cells: Metastasis of Colon Cancer Cells","volume":"143","author":"Zhou","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41420-021-00603-z","article-title":"LIF\/LIFR Oncogenic Signaling Is a Novel Therapeutic Target in Endometrial Cancer","volume":"7","author":"Tang","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41698-021-00218-8","article-title":"Clinical, Genetic and Pharmacological Data Support Targeting the MEK5\/ERK5 Module in Lung Cancer","volume":"5","author":"Pandiella","year":"2021","journal-title":"npj Precis. Oncol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.ymthe.2020.07.003","article-title":"CRISPR\u2014Cas12a with an oAd Induces Precise and Cancer\u2014Specific Genomic Reprogramming of EGFR and Efficient Tumor Regression","volume":"28","author":"Yoon","year":"2020","journal-title":"Mol. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Sakari, M., Suzuki, T., Yano, S., and Tsukahara, T. (2020). Effective RNA Knockdown Using CRISPR\u2014Cas13a and Molecular Targeting of the EML4\u2014ALK Transcript in H3122 Lung Cancer Cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21238904"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Haase-Kohn, C., Laube, M., Donat, C.K., Belter, B., and Pietzsch, J. (2022). CRISPR\/Cas9 Mediated Knockout of Cyclooxygenase -2 Gene Inhibits Invasiveness in A2058 Melanoma Cells. Cells, 11.","DOI":"10.3390\/cells11040749"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1038\/s41598-021-84443-y","article-title":"Knocking out Alpha-Synuclein in Melanoma Cells Dysregulates Cellular Iron Metabolism and Suppresses Tumor Growth","volume":"11","author":"Shekoohi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/php.13305","article-title":"CRISPR\/Cas9-Mediated Knockout of SIRT6 Imparts Remarkable Anti-Proliferative Response in Human Melanoma Cells in Vitro and in Vivo","volume":"96","author":"Ndiaye","year":"2020","journal-title":"Photochem. Photobiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"59476","DOI":"10.18632\/oncotarget.19761","article-title":"Positive Transcription Elongation Factor b (P\u2014TEFb) Is a Therapeutic Target in Human Multiple Myeloma","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijbiomac.2021.03.102","article-title":"Knockout of CD147 Inhibits the Proliferation, Invasion, and Drug Resistance of Human Oral Cancer CAL27 Cells in Vitro and in Vivo","volume":"181","author":"Pan","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"eabc9450","DOI":"10.1126\/sciadv.abc9450","article-title":"CRISPR\u2014Cas9 Genome Editing Using Targeted Lipid Nanoparticles for Cancer Therapy","volume":"6","author":"Rosenblum","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.7150\/jca.28040","article-title":"Knockout of MTF1 Inhibits the Epithelial to Mesenchymal Transition in Ovarian Cancer Cells","volume":"9","author":"Ji","year":"2018","journal-title":"J. Cancer"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jconrel.2019.05.019","article-title":"Knockdown of Hypoxia-Inducible Factor-1 Alpha by Tumor Targeted Delivery of CRISPR\/Cas9 System Suppressed the Metastasis of Pancreatic Cancer","volume":"304","author":"Li","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"11507","DOI":"10.7150\/thno.46642","article-title":"Precise and Efficient Silencing of Mutant Kras $^ \\textrm G12D $ by CRISPR\u2014CasRx Controls Pancreatic Cancer Progression","volume":"10","author":"Jiang","year":"2020","journal-title":"Theranostics"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1177\/1535370218791797","article-title":"FOXA1 Knock-out via CRISPR\/Cas9 Altered Casp -9, Bax, CCND1, CDK4, and Fibronectin Expressions in LNCaP Cells","volume":"243","author":"Albayrak","year":"2018","journal-title":"Exp. Biol. Med."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/18\/2781\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:24:30Z","timestamp":1760142270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/18\/2781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":125,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["cells11182781"],"URL":"https:\/\/doi.org\/10.3390\/cells11182781","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]}}}